The emergence of genome-based drug repositioning

Yves A. Lussier, James L. Chen

Research output: Contribution to journalReview article

55 Scopus citations

Abstract

In a pair of papers in this issue of Science Translational Medicine, Butte et al. provide a concrete example of how reinterpreting and comparing genome-wide metrics allows us to effectively hypothesize which drugs from one disease-indication can be repurposed for another disease. The shift toward integrative genome-wide computational approaches has precedence in insightful scalar theories of biological information. Here, we discuss how this recent work in drug repurposing adheres to and takes advantage of the concepts surrounding this information paradigm.

Original languageEnglish (US)
Article number96ps35
JournalScience translational medicine
Volume3
Issue number96
DOIs
StatePublished - Aug 17 2011
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this